You are here

  • Home
  • Archive
  • Volume 100, Issue 7
  • Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

Article metrics

Article menu
Download PDFPDF
Clinical science
Efficacy of dexamethasone versus bevacizumab on regression of hard exudates in diabetic maculopathy: data from the BEVORDEX randomised clinical trial

 

Online download statistics by month:

Online download statistics by month: November 2015 to July 2020

AbstractFullPdf
Nov 20152854259
Dec 201581511
Jan 2016561412
Feb 2016361311
Mar 201640511
Apr 20163479
May 201652618
Jun 20164811670
Jul 20164981658
Aug 20163461036
Sep 2016117618
Oct 2016102521
Nov 2016116672
Dec 20167359
Jan 201713436
Feb 201760919
Mar 2017481512
Apr 20172184
May 2017361311
Jun 2017851411
Jul 20171011314
Aug 20171391011
Sep 20172251117
Oct 2017347138
Nov 20173242819
Dec 2017165377
Jan 2018176285
Feb 2018189278
Mar 2018151289
Apr 2018284365
May 2018150247
Jun 2018110297
Jul 2018120448
Aug 2018124377
Sep 201867346
Oct 201869142
Nov 201874140
Dec 201887171
Jan 201978153
Feb 201957165
Mar 20194554
Apr 20192610
May 201943154
Jun 201948246
Jul 201933192
Aug 201947191
Sep 201965224
Oct 201948182
Nov 201931215
Dec 201937130
Jan 202042202
Feb 202053307
Mar 202077174
Apr 202085214
May 202078214
Jun 202043152
Jul 202069214
Total6608995682